Back to Search
Start Over
Preoperative gemcitabine-nab-paclitaxel (G-NP) for (borderline) resectable (BLR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC): Feasibility results and early response monitoring by Diffusion-Weighted (DW) MR
- Source :
- Journal of Clinical Oncology. 34:4116-4116
- Publication Year :
- 2016
- Publisher :
- American Society of Clinical Oncology (ASCO), 2016.
-
Abstract
- 4116Background: G-NP has recently emerged as an effective combination treatment for metastatic PDAC. We aimed to evaluate tolerability and activity of induction/neoadjuvant G-NP before surgery. In ...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Pancreatic ductal adenocarcinoma
endocrine system diseases
business.industry
Locally advanced
Gemcitabine
03 medical and health sciences
0302 clinical medicine
Combined treatment
Tolerability
Borderline resectable
030220 oncology & carcinogenesis
Internal medicine
medicine
030211 gastroenterology & hepatology
business
medicine.drug
Nab-paclitaxel
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........5b8e23aa9bc11d4a5466808004df88a9
- Full Text :
- https://doi.org/10.1200/jco.2016.34.15_suppl.4116